176 related articles for article (PubMed ID: 33497978)
1. The potential role of fatty acids in prostate cancer determined by GC-MS analysis of formalin-fixed paraffin-embedded tissue samples.
Buszewska-Forajta M; Raczak-Gutknecht J; Artymowicz M; Wesołowski W; Buczkowski K; Iżycka-Świeszewska E; Markuszewski MJ
J Pharm Biomed Anal; 2021 Mar; 196():113907. PubMed ID: 33497978
[TBL] [Abstract][Full Text] [Related]
2. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
3. Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS.
Neef SK; Winter S; Hofmann U; Mürdter TE; Schaeffeler E; Horn H; Buck A; Walch A; Hennenlotter J; Ott G; Fend F; Bedke J; Schwab M; Haag M
Anal Chim Acta; 2020 Oct; 1134():125-135. PubMed ID: 33059858
[TBL] [Abstract][Full Text] [Related]
4. An Optimized Method of Metabolite Extraction from Formalin-Fixed Paraffin-Embedded Tissue for GC/MS Analysis.
Wojakowska A; Marczak Ł; Jelonek K; Polanski K; Widlak P; Pietrowska M
PLoS One; 2015; 10(9):e0136902. PubMed ID: 26348873
[TBL] [Abstract][Full Text] [Related]
5. Lipidomics as a Diagnostic Tool for Prostate Cancer.
Buszewska-Forajta M; Pomastowski P; Monedeiro F; Walczak-Skierska J; Markuszewski M; Matuszewski M; Markuszewski MJ; Buszewski B
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919225
[TBL] [Abstract][Full Text] [Related]
6. Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer.
Mantsiou A; Makridakis M; Fasoulakis K; Katafigiotis I; Constantinides CA; Zoidakis J; Roubelakis MG; Vlahou A; Lygirou V
J Proteome Res; 2020 Jul; 19(7):2631-2642. PubMed ID: 31682457
[TBL] [Abstract][Full Text] [Related]
7. Targeted metabolomics in formalin-fixed paraffin-embedded tissue specimens: Liquid chromatography-tandem mass spectrometry determination of acidic metabolites in cancer research.
Gomez-Gomez A; Sabbaghi M; Haro N; Albanell J; Menéndez S; González M; Gil-Gómez G; Rovira A; Pozo OJ
Talanta; 2021 Feb; 223(Pt 2):121740. PubMed ID: 33298266
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone.
Xu B; Chen Y; Chen X; Gan L; Zhang Y; Feng J; Yu L
Front Oncol; 2021; 11():730638. PubMed ID: 34722271
[TBL] [Abstract][Full Text] [Related]
9. Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis.
Yu C; Niu L; Li L; Li T; Duan L; He Z; Zhao Y; Zou L; Wu X; Luo C
Prostate; 2021 Dec; 81(16):1320-1328. PubMed ID: 34590739
[TBL] [Abstract][Full Text] [Related]
10. The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalk.
Altuna-Coy A; Ruiz-Plazas X; Sánchez-Martin S; Ascaso-Til H; Prados-Saavedra M; Alves-Santiago M; Bernal-Escoté X; Segarra-Tomás J; R Chacón M
BMC Med; 2022 Aug; 20(1):255. PubMed ID: 35978404
[TBL] [Abstract][Full Text] [Related]
11. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Profiling in Formalin-Fixed and Paraffin-Embedded Prostate Cancer Tissues.
Cacciatore S; Zadra G; Bango C; Penney KL; Tyekucheva S; Yanes O; Loda M
Mol Cancer Res; 2017 Apr; 15(4):439-447. PubMed ID: 28074002
[TBL] [Abstract][Full Text] [Related]
13. Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies.
Carlsson J; Davidsson S; Fridfeldt J; Giunchi F; Fiano V; Grasso C; Zelic R; Richiardi L; Andrén O; Pettersson A; Fiorentino M; Akre O
BMC Med Res Methodol; 2018 Dec; 18(1):161. PubMed ID: 30518332
[TBL] [Abstract][Full Text] [Related]
14. Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study.
Östman JR; Pinto RC; Ebbels TMD; Thysell E; Hallmans G; Moazzami AA
Int J Cancer; 2022 Dec; 151(12):2115-2127. PubMed ID: 35866293
[TBL] [Abstract][Full Text] [Related]
15. New findings on urinary prostate cancer metabolome through combined GC-MS and
Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass Spectrometry.
Yumba-Mpanga A; Struck-Lewicka W; Wawrzyniak R; Markuszewski M; Roslan M; Kaliszan R; Markuszewski MJ
Curr Med Chem; 2019; 26(1):216-231. PubMed ID: 28990506
[TBL] [Abstract][Full Text] [Related]
17. Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data.
Panderi I; Yakirevich E; Papagerakis S; Noble L; Lombardo K; Pantazatos D
Rapid Commun Mass Spectrom; 2017 Jan; 31(2):160-170. PubMed ID: 27791282
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcoma.
Kelly AD; Breitkopf SB; Yuan M; Goldsmith J; Spentzos D; Asara JM
PLoS One; 2011; 6(10):e25357. PubMed ID: 21984915
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
